EUVIMEDEUVIMED entdecken
Crossref

A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants

Catia Carconi, Carlo Bosi, Mario Scartozzi, Massimiliano Cergnul, Marika Cinausero, Luca Faloppi, Ingrid Garajova, Sara Lonardi, Irene Pecora, Laura Pisanu, Rosella Spadi, Andrea Spallanzani und 4 weitere

Pancreatology · 2024

DOI: 10.1016/j.pan.2024.09.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2024. Verfasst von Catia Carconi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffael…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Chlorambucil, Germ-Line Mutation, Antineoplastic Agents, Alkylating. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsChlorambucilGerm-Line MutationAntineoplastic Agents, AlkylatingHumansPilot ProjectsMiddle AgedMaleFemaleAgedAdultAdenocarcinomaDNA RepairBRCA2 ProteinBRCA1 ProteinProgression-Free SurvivalSalvage TherapyNeoplasm MetastasisDNA Damage

Stichwörter der Autor:innen

BRCADNA damage repair systemPancreatic ductal adenocarcinomaSalvage therapy

Substanzen

ChlorambucilAntineoplastic Agents, AlkylatingBRCA2 ProteinBRCA1 ProteinBRCA1 protein, humanBRCA2 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Medical Oncology, University and University Hospital, Cagliari, Italy.
  • Medical Oncology, Ospedale Civile di Legnano - ASST Ovest Milanese, Legnano, Italy.
  • Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale Santa Maria Della Misericordia, Udine, Italy.
  • Medical Oncology Unit, Ospedali Santa Maria Della Pietà e Bartolomeo Eustachio - AST di Macerata, Camerino, San Severino Marche, Italy.
  • Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

Förderung

  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Carconi, C., Bosi, C., Scartozzi, M., Cergnul, M., Cinausero, M., Faloppi, L., Garajova, I., Lonardi, S., Pecora, I., Pisanu, L., Spadi, R., Spallanzani, A., Peretti, U., Macchini, M., Orsi, G., & Reni, M. (2024). A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants. Pancreatology. https://doi.org/10.1016/j.pan.2024.09.006

Vancouver

Carconi C, Bosi C, Scartozzi M, Cergnul M, Cinausero M, Faloppi L, et al. A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants. Pancreatology. 2024. doi:10.1016/j.pan.2024.09.006

BibTeX
@article{Carconi2024,
  author = {Carconi, Catia and Bosi, Carlo and Scartozzi, Mario and Cergnul, Massimiliano and Cinausero, Marika and Faloppi, Luca and Garajova, Ingrid and Lonardi, Sara and Pecora, Irene and Pisanu, Laura and Spadi, Rosella and Spallanzani, Andrea and Peretti, Umberto and Macchini, Marina and Orsi, Giulia and Reni, Michele},
  title = {A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants},
  journal = {Pancreatology},
  year = {2024},
  doi = {10.1016/j.pan.2024.09.006}
}
Kostenlos starten →